index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Anti-agalsidase antibodies Bioelectrical impedance analysis Biomarker Inclusion body myositis Female AAV Middle Aged Anti-drug antibodies Data integration Anti-interleukin-6 Amyotrophy Myositis Antibodies Sphingosine-1-phosphate Antibody responses Acute Kidney Injury/epidemiology/etiology Anti-Mi2 Machine learning B cell homeostasis Anti-MDA5 autoantibodies Amyotrophic lateral sclerosis Lysosomal storage diseases Arthritis Pharmacology Myopathy Anti-IgE IgG Aged Biomarqueurs Anémie hémolytique Active Immunotherapy Antisynthetase Muscle IBM Humans Analyses multidimensionnelles Biomarkers Idiopathic inflammatory myopathies Outcome measures AAV vector Autoantibody AAV antibody DM Myocarditis Autoimmunity Deep immune profiling Prognosis Multidisciplinarity Assisted communication devices Adeno-associated vector Interstitial lung disease Adeno-associated virus vector Immune checkpoint inhibitors Aldosterone Interferon Adolescence Male Acid-alpha-glucosidase Inborn errors of metabolism Aldostérone Animals Adult AAV humoral immunity Mass cytometry Adverse drug reactions Systems biology Cardio-oncology Dermatomyositis Adjudication Autoimmune diseases COVID-19 IMNM Inflammation Fabry disease Inflammatory myopathy Anticorps spécifique des myosites Auto‐antibodies Auto-antibodies Antiphospholipid syndrome AAV vectors Case reports Agalsidase Polymyositis Adeno-associated virus Anti‐mitochondrial antibodies Gene therapy Antisynthétase Anticorps anti-agalsidase Auto-immunité Anti-synthetase syndrome Abnormal movement Antisynthetase syndrome Biopsy Skeletal muscle Myositis and muscle disease Cytokines Cancer Dependovirus/genetics/immunology B-lymphocyte Autoantibodies